A New Era Begins

The acquisition of NanoString’s gene expression profiling and spatial multiomics solutions adds to Bruker’s existing spatial biology portfolio. The combination of Bruker and NanoString’s spatial offerings will provide scientists with more comprehensive solutions to solve complex biological questions from multiple angles.

Bruker Spatial Biology and Cellular Analysis Built Off Key Core Competency in Fluorescence Imaging

NanoString will leverage the core competencies within Bruker and continue to deliver high-performing, innovation across the gene expression and spatial biology continuum.

Bruker Spatial Biology

What the Acquisition Means for You, Our Valued Customer

We are thrilled to share that NanoString Technologies has been acquired by Bruker Corporation, a leading global provider of scientific instruments and solutions. This strategic acquisition marks the beginning of a promising new chapter for NanoString and our valued customers.

Continued Innovation

Bruker has a track record of investing in cutting-edge research and development. This acquisition will enable NanoString to maintain its trajectory of innovation, ensuring that our customers benefit from the latest advancements in spatial biology technology and solutions.

Product Roadmap Confidence

Our commitment to advancing science remains unwavering. With Bruker’s support, we are excited to confirm that the commercialization of our innovative CosMx WTX panel is on track for 2025. This reaffirms our dedication to delivering exceptional products that meet the evolving needs of our customers.

Synergies in Platforms

The complementary nature of NanoString’s platforms with Bruker’s CellScape™ spatial proteomics platform presents unparalleled opportunities for scientific discovery and translational research. This synergy will enable us to offer integrated solutions that unlock new insights and accelerate research outcomes.

Litigation Support

Bruker and NanoString are committed to defending our strong position in our litigation matters.

A Path Forward

Exiting Chapter 11 marks a significant milestone for NanoString. This acquisition not only strengthens our position in the market but also reinforces our dedication to serving our customers with excellence.

In summary, the acquisition of Nanostring by Bruker represents an exciting opportunity for our customers. We are confident that this partnership will fuel innovation, enhance our product offerings, and ultimately enable scientists worldwide to make significant discoveries. We thank you for your continued support and look forward to embarking on this journey together.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.


How do I contact NanoString sales, support and services?

Reach out to your NanoString sales rep, just as you have in the past. There are no changes to our sales and service processes.

Will my NanoString sales rep continue to serve my account?

Yes, NanoString sales reps will continue to service your account. 

Are there any changes planned for customer support or technical assistance?

NanoString’s customer support processes remain in place. Our support teams are eager to readily help customers.

Is NanoString exiting chapter 11 restructuring?

NanoString is out of chapter 11. We are in a strong position financially as part of the Bruker Corporation.

Will customer collaborations with Nanostring continue? 

Yes, NanoString’s collaborations will continue without any changes or disruptions.

Will there be any changes to NanoString’s CRO relationships and network?

NanoString remains CRO-agnostic; all existing CRO relationships remain in place.

Will there be any changes to NanoString’s distributor relationships and network?

The acquisition does not affect our distributor relationships and network. 

Will recent orders be processed, or should they be resubmitted?

There is no need to resubmit any recent orders. They will be processed as usual.